SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0000078003-21-000098
Filing Date
2021-09-17
Accepted
2021-09-17 16:17:55
Documents
2
Group Members
PF EQUITY HOLDINGS 2 B.V.

Document Format Files

Seq Description Document Type Size
1 SC 13D/A ALLOGENE THERAPEUTICS sch13a_allo1.htm SC 13D/A 120880
2 EX-99.1 JOINT FILING AGREEMENT exh99allo.htm EX-99.1 4749
  Complete submission text file 0000078003-21-000098.txt   127264
Mailing Address 235 E 42ND ST NEW YORK NY 10017
Business Address 235 E 42ND ST NEW YORK NY 10017 2125732323
PFIZER INC (Filed by) CIK: 0000078003 (see all company filings)

IRS No.: 135315170 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A
SIC: 2834 Pharmaceutical Preparations

Mailing Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 457-2700
Allogene Therapeutics, Inc. (Subject) CIK: 0001737287 (see all company filings)

IRS No.: 823562771 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-90685 | Film No.: 211260640
SIC: 2836 Biological Products, (No Diagnostic Substances)